Patexia Logo
Patexia Logo
Products
  • IP Intelligence Reports
  • Patexia Concierge
  • Patent Analyzer
  • Trademarks Analyzer
  • Litigation Analyzer
  • All Products
Services
  • Lateral Opportunities
  • Expert Witness
  • Research Studies
  • Strategic Partnership
  • All Services
IP Community
  • IP Community
  • IP Webinars
  • In the News
Company
  • About Us
  • Press Release
  • Careers
  • Contact Us
Login
JoinBook a Meeting
Patexia Logo
Products
  • IP Intelligence Reports
  • Patexia Concierge
  • Patent Analyzer
  • Trademarks Analyzer
  • Litigation Analyzer
Services
  • Lateral Opportunities
  • Expert Witness
  • Research Studies
  • Strategic Partnership
Company
  • About Us
  • Press Release
  • Careers
  • Contact Us
Resources
  • IP Community
  • IP Webinars
  • In the News
  • Help Center
Contact
  • (310) 909-7611
  • 100 Wilshire Blvd. Suite 700
    Santa Monica, CA 90401 USA
  • info@patexia.com
  • Send a message
Follow Us
Terms and Conditions|Privacy Policy
© 2010-2023 Patexia Inc. All Rights Reserved.
Back to All Articles
Browse articles with tag: Biosimilars
You must be logged in to create a new article
All Articles
Mikele Bicolli
Nov 9, 2022
•
Patent Litigation
The U.S. Supreme Court is About to Ultimately Decide Amgen vs Sanofi Antibody Patent Case
Most of the community involved in life science litigation and pharmaceutical companies, thought they saw the end of the long-fought... Read More
Pedram Sameni
Nov 3, 2022
•
ANDA Litigation
Patexia Insight 157: Most Active Companies in Biosimilar Litigation (BPCIA Act)
In late August, we published our third annual ANDA Litigation Intelligence Report. We evaluated the stakeholders for Hatch-Waxman cases filed... Read More
Pedram Sameni
Sep 22, 2022
•
ANDA Litigation
Patexia Insight 152: Best Performing Brand and Generic Pharmas of 2022 (ANDA)
Last month, we released our third annual ANDA Litigation Intelligence Report evaluating all stakeholders in ANDA/Hatch-Waxman cases filed over the... Read More
Pedram Sameni
Sep 15, 2022
•
ANDA Litigation
Patexia Insight 151: ANDA Litigators Who Moved in the Last 12 Months
In late August we released our third annual ANDA Litigation Intelligence Report. The report covered the ANDA litigation landscape by... Read More
Mikele Bicolli
Aug 28, 2022
•
Patent Litigation
Pfizer and BioNTech Strike Back to CureVac's Lawsuit by Seeking Declaratory Judgment of Noninfringement | Who Will Control mRNA Tech?
Two days ago, the companies that joined forces in order to develop the first Covid vaccine that got approval for... Read More
Mikele Bicolli
Aug 27, 2022
•
Patent Litigation
Pfizer and BioNTech Sued Again Over Covid Vaccine Technology, This Time by Moderna
Less than two months ago, Curevac filed a lawsuit in the German Regional Court in Düsseldorf against BioNTech over patent... Read More
  • <
  • 1
  • 2
  • 3
  • >